1. Describe the various clinical presentations of joint pain in the IBD population.


2. Understand the overlapping immunopathology between inflammatory bowel disease (IBD) and other forms of spondyloarthritis (SpA).


3. Discuss current treatment strategies aimed at controlling the extra-gastrointestinal disease.


4. Evaluate potential of newer drugs to address these symptoms.


Session date: 
11/28/2017 - 8:30am to 9:30am CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Reem Jan, M.D.